| Trial ID: | L5876 |
| Source ID: | NCT00136773
|
| Associated Drug: |
Amlodipine/Benazepril
|
| Title: |
Effects of Amlodipine/Benazepril on Albuminuria in Hypertensive Patients With Type 2 Diabetes Mellitus
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Albuminuria
|
| Interventions: |
DRUG: amlodipine/benazepril
|
| Outcome Measures: |
Primary: Change from baseline in the urine albumin/creatinine ratio after 52 weeks | Secondary: Percentage of patients who have progressed to diabetic kidney disease (urine albumin/creatinine ratio ≥ 300 µg/mg creatinine) after 52 weeks|Change from baseline in the ratio of urine albumin/creatinine ratio an estimate of kidney function after 52 weeks|Change from baseline in insulin resistance after 52 weeks|Change from baseline in urine albumin secretion after 52 weeks|Change from baseline in a marker of heart failure after 52 weeks
|
| Sponsor/Collaborators: |
Sponsor: Novartis
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
332
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
|
| Start Date: |
2003-04
|
| Completion Date: |
2005-11
|
| Results First Posted: |
|
| Last Update Posted: |
2011-03-09
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00136773
|
